Literature DB >> 1248984

Augmentation of sickling process due to turbulent blood flow.

P D Stein, H N Sabbah, A K Mandal.   

Abstract

The purpose of this study was to determine if the fluid mechanical stresses associated with turbulent blood flow can contribute to the sickling process. Blood from seven patients with sickle cell disease was subjected to intermediate and high levels of turbulent flow in vitro. Turbulence was quantitated by hot film anemometry. Control samples showed 20 +/- 3% sickled cells. Cells subjected to intermediate levels of turbulent flow showed 26 +/- 4% sickling (P less than 0.01); and blood subjected to high intensities of turbulence showed 31 +/- 4% sickling (P less than 0.01). A quantitative count by electronmicroscopy, performed in one patient, showed polymerization of the hemoglobin indicative of sickling in more cells subjected to turbulence than in the control sample. A turbulence-reducing agent, polyethylene oxide, diminished the augmentation of the sickling process as it reduced turbulence at comparable Reynolds numbers. These results support the hypothesis that a deleterious effect upon hemoglobin SS erythrocytes may occur due to the mechanical stresses of turbulent flow. The agitation associated with turbulent flow presumably modifies the stabilizing factors of the intracellular colloidal solution of hemoglobin, thereby contributing to sol-gel transformation. Such hydrodynamic stresses may supplement the previously described factors which contribute to sickle cell crises.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1248984     DOI: 10.1152/jappl.1976.40.1.60

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


  2 in total

1.  Electron microscope study of the kinetics of the fiber-to-crystal transition of sickle cell hemoglobin.

Authors:  S M Wilson; M W Makinen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

2.  Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease.

Authors:  Ciprian B Anea; Matthew Lyon; Itia A Lee; Joyce N Gonzales; Amidat Adeyemi; Greer Falls; Abdullah Kutlar; Julia E Brittain
Journal:  Am J Hematol       Date:  2016-02       Impact factor: 10.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.